Mount Sinai deploys analytics and artificial intelligence to take on congestive heart failure

Mount Sinai Health System announced that it has tapped CloudMedx to help pinpoint people at risk of congestive heart failure as part of its emerging program dubbed HealthPromise. The plan is to harness CloudMedx predictive insights for evidence-based care interventions to reduce readmissions and, ultimately, improve patient outcomes. "We are passionate about bringing advanced analytics to the forefront of managing our chronic patients and improving our patient well-being," Ashish Atreja, MD, chief technology innovation and engagement officer in medicine at Icahn School of Medicine at Mount Sinai, said in a statement. "As an industry, we do not have a sufficiently sophisticated tool to predict certain things such as disease progression and resulting readmissions in hospitals," Atreja added. "We are working with CloudMedx to use new guidelines and algorithms, using clinical data to determine these risks and predictors." Atreja explained that the CloudMedx AI platform can ingest and process large amounts of data and compute big data analytics.